Aeglea BioTherapeutics, Inc. (AGLE): Price and Financial Metrics
AGLE Price/Volume Stats
| Current price | $12.01 | 52-week high | $32.75 |
| Prev. close | $11.04 | 52-week low | $2.66 |
| Day low | $10.69 | Volume | 43,300 |
| Day high | $12.34 | Avg. volume | 95,409 |
| 50-day MA | $11.42 | Dividend yield | N/A |
| 200-day MA | $9.59 | Market Cap | 48.63M |
AGLE Stock Price Chart Interactive Chart >
Aeglea BioTherapeutics, Inc. (AGLE) Company Bio
Aeglea Biotherapeutics, Inc., a biopharmaceutical company, engages in developing engineered human enzymes for the treatment of inborn errors of metabolism and cancer. The company was founded in 2013 and is based in Austin, Texas.
AGLE Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 15.59% |
| 3-year | -92.40% |
| 5-year | -94.30% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -90.53% |
| 2021 | -39.64% |
| 2020 | 3.01% |
| 2019 | 2.00% |
Loading social stream, please wait...